Rezension:
Could I order a new chequebook, please? who can write me a book report Flutiform is currently marketed for bronchial asthma in 12 European countries, and is approved in Israel, Australia and Hong Kong. Skyepharma chief executive Peter Grant said that “we look forward to the results of the COPD trials and to the continued roll-out of Flutiform by Mundipharma, which is already providing many asthma patients with a new and effective treatment option”.
